| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |